FDA Discontinues Production of Teva's Irinotecan Injection (20 MG/1 ML)
RefinitivMenos de 1 minuto de lectura
FDA:
FDA: DISCONTINUES MANUFACTURING OF TEVA PHARMACEUTICALS USA'S IRINOTECAN HYDROCHLORIDE, INJECTION, 20 MG/1 ML- WEBSITE
FDA: IRINOTECAN HYDROCHLORIDE, INJECTION, 20 MG/1 ML NOT ANTICIPATED TO BE AVAILABLE BEYOND MID-LATE OCT 2025
Inicie sesión o cree una cuenta gratuita y permanente para leer esta noticia